The hyperPP component would result from gain-of-function effects of the mutation whereas the hypokalaemic episodes would result from the exacerbation of loss-of-function effects on Nav1.4 by hypokalaemia whose physiological basis remains to be determined. This evidence concerns the gene SCN4A and Hypokalemia.